APA (7th ed.) Citation

Dale, G. E., Halabi, A., Petersen-Sylla, M., Wach, A., & Zwingelstein, C. (2018). Pharmacokinetics, Tolerability, and Safety of Murepavadin, a Novel Antipseudomonal Antibiotic, in Subjects with Mild, Moderate, or Severe Renal Function Impairment. Antimicrobial agents and chemotherapy, 62(9), . https://doi.org/10.1128/AAC.00490-18

Chicago Style (17th ed.) Citation

Dale, Glenn E., Atef Halabi, Marc Petersen-Sylla, Achim Wach, and Christian Zwingelstein. "Pharmacokinetics, Tolerability, and Safety of Murepavadin, a Novel Antipseudomonal Antibiotic, in Subjects with Mild, Moderate, or Severe Renal Function Impairment." Antimicrobial Agents and Chemotherapy 62, no. 9 (2018). https://doi.org/10.1128/AAC.00490-18.

MLA (9th ed.) Citation

Dale, Glenn E., et al. "Pharmacokinetics, Tolerability, and Safety of Murepavadin, a Novel Antipseudomonal Antibiotic, in Subjects with Mild, Moderate, or Severe Renal Function Impairment." Antimicrobial Agents and Chemotherapy, vol. 62, no. 9, 2018, https://doi.org/10.1128/AAC.00490-18.